Benzodiazepine APIs Market Projected to Hit USD652.8 Mn by 2031 with a 3.6% CAGR: TMR Report Wilmington, Delaware, United States, June 22, 2023 (GLOBE NEWSWIRE) -- In 2022, the benzodiazepine APIs market was estimated to be worth US$ 472.8 million. It is expected to grow at a 3.6% CAGR from...

Assertio Holdings, Inc. Announces FDA Orange Book Listing for New Sympazan® Oral Film Patent LAKE FOREST, Ill., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...

Assertio Holdings, Inc. Signs Exclusive License for Sympazan® (clobazam) Oral Film from Aquestive Therapeutics, Inc. Trailing 12 Month Revenues of Sympazan Were $9.5 MillionAssertio Paid $9.0 Million Upfront, Additional $6.0 Million upon Patent Allowance LAKE FOREST, Ill., Oct. 27, 2022 (GLOBE NEWSWIRE) --...

Global Epilepsy Drugs Market (2020 to 2027) - Featuring UCB, Eisai, H. Lundbeck and GW Pharmaceuticals Dublin, Sept. 15, 2021 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Global Forecast, Impact of COVID-19, Industry Trends, by Drugs Category, Growth, Opportunity Company Analysis" report has been...